PEN Penumbra Inc

Price (delayed)

$129.31

Market cap

$4.87B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.19

Enterprise value

$5.02B

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses ...

Highlights
PEN's equity is up by 46% year-on-year
PEN's gross profit is up by 36% year-on-year and by 3.4% since the previous quarter
Penumbra's debt has surged by 185% YoY and by 26% QoQ
The net income has decreased by 22% YoY

Key stats

What are the main financial stats of PEN
Market
Shares outstanding
37.68M
Market cap
$4.87B
Enterprise value
$5.02B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.08
Price to sales (P/S)
6.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.42
Earnings
Revenue
$782.28M
EBIT
-$26.28M
EBITDA
-$7.61M
Free cash flow
-$2.79M
Per share
EPS
-$0.19
Free cash flow per share
-$0.07
Book value per share
$25.48
Revenue per share
$20.78
TBVPS
$27.81
Balance sheet
Total assets
$1.3B
Total liabilities
$342.27M
Debt
$218.99M
Equity
$959.3M
Working capital
$560.23M
Liquidity
Debt to equity
0.23
Current ratio
5.31
Quick ratio
2.95
Net debt/EBITDA
-19.81
Margins
EBITDA margin
-1%
Gross margin
62.8%
Net margin
-0.8%
Operating margin
-3.2%
Efficiency
Return on assets
-0.6%
Return on equity
-0.8%
Return on invested capital
-2.7%
Return on capital employed
-2.2%
Return on sales
-3.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PEN stock price

How has the Penumbra stock price performed over time
Intraday
3.18%
1 week
3.85%
1 month
-8.84%
1 year
-53.04%
YTD
-54.99%
QTD
3.85%

Financial performance

How have Penumbra's revenue and profit performed over time
Revenue
$782.28M
Gross profit
$491.46M
Operating income
-$25.01M
Net income
-$6.47M
Gross margin
62.8%
Net margin
-0.8%
PEN's gross profit is up by 36% year-on-year and by 3.4% since the previous quarter
PEN's revenue is up by 32% year-on-year and by 4.6% since the previous quarter
PEN's operating margin is up by 27% YoY
The net income has decreased by 22% YoY

Growth

What is Penumbra's growth rate over time

Valuation

What is Penumbra stock price valuation
P/E
N/A
P/B
5.08
P/S
6.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.42
PEN's EPS is down by 19% YoY
The stock's P/B is 60% below its last 4 quarters average of 12.2 and 56% below its 5-year quarterly average of 11.1
PEN's equity is up by 46% year-on-year
PEN's price to sales (P/S) is 55% lower than its last 4 quarters average of 13.4 and 48% lower than its 5-year quarterly average of 11.6
PEN's revenue is up by 32% year-on-year and by 4.6% since the previous quarter

Efficiency

How efficient is Penumbra business performance
The company's return on invested capital has shrunk by 200% QoQ but it rose by 13% YoY
The ROA has grown by 14% YoY
PEN's ROS is up by 6% YoY

Dividends

What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PEN.

Financial health

How did Penumbra financials performed over time
PEN's total liabilities has soared by 80% YoY and by 18% from the previous quarter
Penumbra's total assets has soared by 55% YoY and by 4.6% from the previous quarter
Penumbra's debt is 77% lower than its equity
Penumbra's debt has surged by 185% YoY and by 26% QoQ
PEN's debt to equity has surged by 92% year-on-year and by 28% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.